Finland· FI-REL-REL52659

Spasmipur vet.

A butyyliskopolamiini product containing hyoscine butylbromide, registered in Finland by VetViva Richter GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC QA03BB01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSpasmipur vet.ATCQA03BB01REGISTER NO.FI-REL-REL52659PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Hyoscine butylbromide is registered in 2 of 19 countries.

Countries holding a registration under ATC QA03BB01 (butyyliskopolamiini), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Hyoscine butylbromide · ATC QA03BB01

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Hyoscine butylbromide
Manufacturer
VetViva Richter GmbH
Country
Finland (FI)
ATC code
QA03BB01
ATC class
Butyyliskopolamiini
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hyoscine butylbromide in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hyoscine butylbromide products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Buscapina, Buscopan
  • Belgium · Buscopan, Buscopan Forte
  • Bulgaria · Бусколизин, Бусколизин Форте
  • Cyprus · Avotrin, Buscopan
  • Czechia · Buscopan, Butylskopolaminium Bromid Kalceks
  • Germany · Buscopan, Buscopan Ampullen
  • Denmark · Bumacor
  • Estonia · Bysimin
  • Spain · Buscapina, Buscopresc
  • France · Buscopan, Scoburen
  • United Kingdom (Northern Ireland) · Almus Ibs Relief, Almus Stomach Cramp Relief
  • Greece · Avotrin, Buscopan
  • Croatia · Buscopan, Bysimin
  • Hungary · Buscopan, Buscopan Forte
  • Ireland · Buscopan, Buscopan Ampoules
  • Italy · Addofix, Buscopan
  • Luxembourg · Buscopan, Buscopan Forte
  • Latvia · Buscopan, Hyoscine Butylbromide Kalceks
  • Malta · Buscopan, Buscopan Ampoules
  • Netherlands · Buscopan, Scopolamine Butylbromide Kalceks
  • Norway · Bumacor, Buscopan
  • Poland · Aurogastro, Buscolysin
  • Portugal · Buscopan, Butilescopolamina Conforpam
  • Romania · Buscopan, Buscotil
  • Sweden · Bumacor, Buscopan
  • Slovenia · Buscopan
  • Slovakia · Buscopan, Scopolamine Butylbromide Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4e6090af-a699-4330-9ee6-d971fd6a8255
GET /v1/drugs/4e6090af-a699-4330-9ee6-d971fd6a8255?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": "Laskimoon",
  "ddd_unit": null,
  "strength": "20 mg/ml",
  "atc_label": "Butyyliskopolamiini",
  "ma_number": "36007",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL52659",
  "authorised_at": "2019-03-18"
}

See everything about hyoscine butylbromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.